Joyful News

Nanjing Chiheal Bio Medicine Technology Co., Ltd successfully passed the evaluation for the national "Specialized, Refined, Characteristic, and Innovative" (Little giants) enterprise, thanks to its comprehensive corporate strength, and was granted the title of:

“Little giants”!

Little giants are the top performers among specialized, high-end and innovation-driven SMEs that provide distinctive products or services. (These SMEs are distinguished by their focus on niche markets, strong innovation capabilities, large market share, and strengths in core technologies, which enable them to have outstanding achievements.)

Recently, the Ministry of Industry and Information Technology of the People's Republic of China issued the "Announcement on the Release of the List of the Sixth Batch of National Specialized, Refined, Characteristic, and Innovative (Little giants) Enterprises and the List of Enterprises Approved in the Third Batch of National Specialized, Refined, Characteristic, and Innovative (Little giants) Enterprise Evaluation" (MIIT Enterprise Letter [2024] No. 317), which published the list of the sixth batch of national "Specialized, Refined, Characteristic, and Innovative (Little giants)" enterprises and the list of enterprises that passed the evaluation in the third batch.

Nanjing Chiheal Bio Medicine Technology Co., Ltd successfully passed the evaluation for the national "Specialized, Refined, Characteristic, and Innovative (Little giants)" enterprise, thanks to its comprehensive corporate strength, and was awarded the honorary title!

"Specialized, Refined, Characteristic, and Innovative" refers to enterprises with the "Four Characteristics"—"professionality, refinement, distinctiveness, and innovation." Among these, the "Specialized, Refined, Characteristic, and Innovative (Little giants)" enterprises are the elite competitors who focus on niche markets, possess strong innovation capabilities, hold high market share, control key core technologies, and excel in quality and efficiency.

The title of "Specialized, Refined, Characteristic, and Innovative (Little giants)" not only highlights the enterprise’s outstanding capabilities in its respective field, particularly in technical innovation and in-depth focus, but also reflects its high-quality development achievements and excellent market performance. As key technology-driven enterprises supported by the state, "Specialized, Refined, Characteristic, and Innovative (Little giants)" enterprises have become a backbone force in driving industrial upgrading and promoting high-quality economic development.

Chiheal Bio-Tech’s inclusion in this list is a strong acknowledgement from the government of our company’s core competitiveness in the pharmaceutical field, as well as an affirmation of our ongoing innovation and pursuit of excellence. This honor not only injects strong momentum into the company’s future development, but also motivates Chiheal Bio-Tech to persist in upholding its corporate mission— “Continuous Innovation, Enhancing Services, and Empowering the Sustainable Development of the Pharmaceutical Industry.”

The company will continue to increase investment in research and development, deepen technological innovation, strengthen core competitiveness, improve service quality, and strive to achieve new leaps in innovation capacity and overall strength. We are committed to making greater contributions to promoting the high-quality development of China’s pharmaceutical industry.